HeadInvest LLC’s Pfizer PFE Stock Holding History

HeadInvest LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,398	Closed	-$292K	–	226
2026 Q1	$292K	Sell	10,398 -2,387	-19%	-$63.5K	0.06%	185
2025 Q4	$318K	Sell	12,785 -1,042	-8%	-$26.3K	0.06%	177
2025 Q3	$352K	Sell	13,827 -3,762	-21%	-$92.9K	0.07%	170
2025 Q2	$426K	Sell	17,589 -4,366	-20%	-$102K	0.09%	152
2025 Q1	$556K	Sell	21,955 -695	-3%	-$18.2K	0.11%	139
2024 Q4	$601K	Sell	22,650 -4,789	-17%	-$130K	0.11%	135
2024 Q3	$794K	Buy	27,439 +698	+3%	+$20.4K	0.15%	113
2024 Q2	$748K	Buy	26,741 +154	+0.6%	+$4.24K	0.15%	109
2024 Q1	$738K	Sell	26,587 -1,285	-5%	-$35.7K	0.14%	106
2023 Q4	$802K	Sell	27,872 -3,967	-12%	-$120K	0.17%	99
2023 Q3	$1.08M	Sell	31,839 -426	-1%	-$15.1K	0.23%	80
2023 Q2	$1.16M	Buy	32,265 +1,090	+3%	+$42.4K	0.25%	79
2023 Q1	$1.27M	Sell	31,175 -14,173	-31%	-$612K	0.28%	74
2022 Q4	$2.32M	Sell	45,348 -751	-2%	-$36K	0.52%	50
2022 Q3	$2.02M	Buy	46,099 +1,050	+2%	+$51K	0.48%	51
2022 Q2	$2.36M	Buy	45,049 +511	+1%	+$26K	0.53%	48
2022 Q1	$2.31M	Buy	44,538 +281	+0.6%	+$14.6K	0.44%	52
2021 Q4	$2.61M	Buy	44,257 +25	+0.1%	+$1.24K	0.46%	52
2021 Q3	$1.9M	Sell	44,232 -6	-0%	-$266	0.36%	56
2021 Q2	$1.73M	Sell	44,238 -575	-1%	-$22.4K	0.33%	60
2021 Q1	$1.62M	Buy	44,813 +576	+1%	+$20.5K	0.33%	60
2020 Q4	$1.63M	Buy	44,237 +289	+0.7%	+$10.6K	0.35%	58
2020 Q3	$1.53M	Buy	43,948 +3,326	+8%	+$117K	0.44%	51
2020 Q2	$1.26M	Buy	40,622 +6,408	+19%	+$218K	0.4%	53
2020 Q1	$1.06M	Buy	34,214 +1,267	+4%	+$43.2K	0.4%	54
2019 Q4	$1.23M	Buy	32,947 +611	+2%	+$21.8K	0.35%	57
2019 Q3	$1.1M	Buy	32,336 +126	+0.4%	+$4.58K	0.33%	61
2019 Q2	$1.32M	Buy	32,210 +632	+2%	+$25.1K	0.37%	56
2019 Q1	$1.27M	Sell	31,578 -31,578	-50%	-$1.26M	0.36%	58
2018 Q4	$2.62M	Buy	63,156 +31,473	+99%	+$1.31M	0.41%	54
2018 Q3	$1.32M	Buy	31,683 +58	+0.2%	+$2.23K	0.38%	55
2018 Q2	$1.09M	Sell	31,625 -133	-0.4%	-$4.54K	0.33%	57
2018 Q1	$1.07M	Sell	31,758 -158	-0.5%	-$5.43K	0.34%	59
2017 Q4	$1.1M	Hold	31,916	–	–	0.34%	58
2017 Q3	$1.06M	Sell	31,916 -733	-2%	-$23.6K	0.33%	59
2017 Q2	$1.04M	Sell	32,649 -105	-0.3%	-$3.31K	0.34%	61
2017 Q1	$1.06M	Sell	32,754 -200	-0.6%	-$6.31K	0.36%	59
2016 Q4	$1.02M	Buy	32,954 +3,899	+13%	+$119K	0.38%	61
2016 Q3	$926K	Hold	29,055	–	–	0.33%	62
2016 Q2	$971K	Sell	29,055 -527	-2%	-$16.8K	0.37%	57
2016 Q1	$832K	Hold	29,582	–	–	0.33%	59
2015 Q4	$906K	Sell	29,582 -426	-1%	-$13.4K	0.37%	55
2015 Q3	$894K	Sell	30,008 -3,060	-9%	-$98.1K	0.36%	55
2015 Q2	$1.05M	Hold	33,068	–	–	0.39%	54
2015 Q1	$1.09M	Buy	33,068 +211	+0.6%	+$6.71K	0.39%	55
2014 Q4	$971K	Hold	32,857	–	–	0.39%	53
2014 Q3	$934K	Sell	32,857 -202	-0.6%	-$5.67K	0.37%	55
2014 Q2	$931K	Sell	33,059 -287	-0.9%	-$8.18K	0.38%	55
2014 Q1	$1.02M	Sell	33,346 -211	-0.6%	-$6.29K	0.44%	52
2013 Q4	$975K	Sell	33,557 -319	-0.9%	-$9.28K	0.41%	52
2013 Q3	$923K	Buy	33,876 +317	+0.9%	+$8.63K	0.4%	52
2013 Q2	$892K	Buy	+33,559	New	+$927K	0.39%	53

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HeadInvest LLC's PFE Position: Q2 2026 in Review

HeadInvest LLC sold out of Pfizer (PFE) in Q2 2026, closing a stake of 10,398 shares — an estimated $292K sold.

HeadInvest LLC first reported a position in PFE in Q2 2013 and held it in 52 quarters. The position peaked at $2.62M in Q4 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

HeadInvest LLC reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
HeadInvest LLC sold 10,398 Pfizer shares in Q2 2026, an estimated $292K.
HeadInvest LLC first reported a position in Pfizer in Q2 2013 and held it in 52 quarters.
HeadInvest LLC's Pfizer position peaked at $2.62M in Q4 2018.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HeadInvest LLC's 13F filing for Q2 2026, filed 14 Aug 2026.